Similar to prostate and melanoma models, we have found that AML EVs suppress T cell activation and adsorb anti-PD-L1 antibodies, suggesting that EVs may also contribute to immune checkpoint inhibitor resistance in AML (Figure 3C) (Butler, unpublished). The gene discussed is CD274; the disease is melanoma.